NEW YORK – Qiagen announced on Tuesday that the German Federal Patent Court has ruled in its favor regarding a patent infringement lawsuit it filed against SD Biosensor. The patent in question — ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

The test, which runs on the Swiss company's high-throughput MosaiQ System, detects 15 different autoantibodies.